Editorial: Post COVID-19: the nucleoside-modified messenger RNA (modRNA) platform

Editorial: Post COVID-19: the nucleoside-modified messenger RNA (modRNA) platform

Bibliographic Details
Main Authors:	Luca Roncati, Qun Treen Huo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Medicine
Subjects:	Coronavirus Disease 2019 (COVID-19) vaccine messenger RNA (mRNA) nucleoside-modified mRNA (modRNA) nanoparticles dendritic cells personalized oncology
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1324610/full

Similar Items

Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery
by: Magdalena M. Żak, et al.
Published: (2021-10-01)

A Three-Case Series of Thrombotic Deaths in Patients over 50 with Comorbidities Temporally after modRNA COVID-19 Vaccination
by: Luca Roncati, et al.
Published: (2022-04-01)

A Real-World Nationwide Study on COVID-19 Trend in Italy during the Autumn–Winter Season of 2020 (before Mass Vaccination) and 2021 (after Mass Vaccination) Integrated with a Retrospective Analysis of the Mortality Burden per Year
by: Luca Roncati, et al.
Published: (2024-02-01)

mRNA in the Context of Protein Replacement Therapy
by: Theofanis Vavilis, et al.
Published: (2023-01-01)

Cell-Specific mRNA Therapeutics for Cardiovascular Diseases and Regeneration
by: Raj Kishore, et al.
Published: (2024-01-01)

Efficient Messenger RNA Delivery to the Kidney Using Renal Pelvis Injection in Mice
by: Natsuko Oyama, et al.
Published: (2021-10-01)

Deconvolution of synthetic mRNA expression: Nucleoside chemistry alters translatability
by: Hanieh Moradian, et al.
Published: (2024-07-01)

CleanCap M6 inhibits decapping of exogenously delivered IVT mRNA
by: Zachary F. Mandell, et al.
Published: (2025-03-01)

mRNA‐based chimeric antigen receptor T cell therapy: Basic principles, recent advances and future directions
by: Kaiting Xiao, et al.
Published: (2024-01-01)

PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials
by: Naoto Yoshinaga, et al.
Published: (2021-05-01)

Cubital Tunnel Syndrome Temporally after COVID-19 Vaccination
by: Luca Roncati, et al.
Published: (2022-04-01)

Matrices Activated with Messenger RNA
by: Raquel Martinez-Campelo, et al.
Published: (2023-01-01)

The Pivotal Role of Chemical Modifications in mRNA Therapeutics
by: Albert Liu, et al.
Published: (2022-07-01)

Double-stranded RNA reduction by chaotropic agents during in vitro transcription of messenger RNA
by: Xijun Piao, et al.
Published: (2022-09-01)

Modified mRNA Formulation and Stability for Cardiac and Skeletal Muscle Delivery
by: Magdalena M. Żak, et al.
Published: (2023-08-01)

The potential of N2-modified cap analogues for precise genetic manipulation through mRNA engineering
by: Karol Kurpiejewski, et al.
Published: (2024-02-01)

Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method
by: Min Tang, et al.
Published: (2023-04-01)

Engineered exosomes enriched in netrin-1 modRNA promote axonal growth in spinal cord injury by attenuating inflammation and pyroptosis
by: Xiao Lu, et al.
Published: (2023-01-01)

Capillary electrophoresis methods for determining the IVT mRNA critical quality attributes of size and purity
by: Denise A Warzak, et al.
Published: (2023-10-01)

RNA in axons, dendrites, synapses and beyond
by: Richard Taylor, et al.
Published: (2024-09-01)

mRNA-Based Therapeutics in Cancer Treatment
by: Han Sun, et al.
Published: (2023-02-01)

mRNA therapeutics: New vaccination and beyond
by: Huan-Huan Wei, et al.
Published: (2023-09-01)

Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery
by: Xuan Du, et al.
Published: (2023-09-01)

Modeling the effect of rRNA-mRNA interactions and mRNA folding on mRNA translation in chloroplasts
by: Stav Carmel Ezra, et al.
Published: (2022-01-01)

Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy
by: Yusi Wang, et al.
Published: (2022-02-01)

Editorial: RNA vaccines for prevalent and newly emerging diseases
by: César López-Camacho, et al.
Published: (2024-08-01)

CircRNA/miRNA/mRNA axis participates in the progression of partial bladder outlet obstruction
by: Baoyi Zhu, et al.
Published: (2022-11-01)

Cotranslational microRNA mediated messenger RNA destabilization
by: Trinh To Tat, et al.
Published: (2016-04-01)

Effective Synthesis of mRNA during In Vitro Transcription with Fewer Impurities Produced
by: Wei He, et al.
Published: (2024-10-01)

Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration
by: Xueliang Yu, et al.
Published: (2021-11-01)

Non-coding functions of alternative pre-mRNA splicing in development
by: Mockenhaupt, Stefan, et al.
Published: (2016)

Non-coding functions of alternative pre-mRNA splicing in development
by: Mockenhaupt, Stefan, et al.
Published: (2015)

Development of mRNA rabies vaccines
by: Zixin Fang, et al.
Published: (2024-12-01)

Regulation of SUMOylation on RNA metabolism in cancers
by: Yingting Cao, et al.
Published: (2023-02-01)

Analyses of lncRNA and mRNA profiles in recurrent atrial fibrillation after catheter ablation
by: Huaiguang Tang, et al.
Published: (2024-04-01)

Transcriptome-wide 1-methyladenosine functional profiling of messenger RNA and long non-coding RNA in bladder cancer
by: Jian-jian Yin, et al.
Published: (2024-02-01)

Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy
by: Yuxiang Zhao, et al.
Published: (2023-10-01)

Nuclear mRNA export
by: Chen Suli, et al.
Published: (2024-09-01)

mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
by: Yu-Shiuan Wang, et al.
Published: (2023-10-01)

An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
by: Md. Motiar Rahman, et al.
Published: (2021-03-01)